- Sniper heaven: Pentagon’s self-guided bullets leave enemies nowhere to hide
- Violent gang taking advantage of immigration crisis, using border as recruiting hub
- Medicaid enrollment continues to soar under Obamacare, administration says
- Michelle Obama to Latinos: ‘We cannot afford to wait on Congress’ for immigration
- White House urges GOP to act ‘urgently’ on $3.7 billion request for illegal immigrants
- Politicians, criminals using ‘right-to-be-forgotten’ law EU courts forced upon Google
- Combat fatigue: elite special forces troops are ‘fraying,’ Gen. Joseph Votel warns
- German foreign minister to meet Kerry to discuss spying claims
- Florida police spokesman tells citizens: ‘Get yourself some firearms’
- California church handing out ‘travel cash’ to illegals heading east
Expiring patents on drugs to slash cost
Generics nearing for Lipitor, Plavix
Question of the Day
The cost of prescription medicines used by millions of people every day is about to plummet.
The next 14 months will bring generic versions of seven of the world’s 20 best-selling drugs, including the top two, cholesterol fighter Lipitor and blood thinner Plavix.
The magnitude of this wave of expiring drug patents is unprecedented. Between now and 2016, blockbusters with about $255 billion in global annual sales are set to go off patent, notes EvaluatePharma Ltd., a London research firm. Generic competition will crush sales of the brand-name drugs and slash the cost to patients and companies that provide health benefits.
Top drugs getting generic competition by September 2012 are taken by millions every day: Lipitor alone is taken by about 4.3 million Americans and Plavix by 1.4 million. Generic versions of big-selling drugs for blood pressure, asthma, diabetes, depression, high triglycerides, HIV and bipolar disorder also are coming by then.
The flood of generics will continue for the next decade or so, as about 120 brand-name prescription drugs lose market exclusivity, according to prescription-benefit manager Medco Health Solutions Inc.
“My estimation is at least 15 percent of the population is currently using one of the drugs whose patents will expire in 2011 or 2012,” says Joel Owerbach, chief pharmacy officer for Excellus Blue Cross Blue Shield, which serves most of upstate New York.
Those patients, along with businesses and taxpayers who help pay for prescription drugs through corporate and government prescription plans, collectively will save a small fortune. That’s because generic drugs typically cost 20 percent to 80 percent less than the brand names.
Doctors hope the lower prices will significantly reduce the number of people jeopardizing their health because they can’t afford medicines they need. Dr. Nieca Goldberg, director of the Women’s Heart Program at NYU Langone Medical Center, worries about patients who are skipping checkups and halving pills.
“You can pretty much tell by the numbers when I check the patient’s blood pressure or cholesterol levels,” that they’ve not taken their medications as prescribed, she says.
TWT Video Picks
By Tammy Bruce
The EPA takes its cue from rogue president on wage-garnishment scheme
- Armed militia sets up Texas command center to 'fight for national sovereignty'
- Va. Democrat reportedly seeks nude shots of Kendall Jones
- Obama seeks brisk passage of border children funding bill
- Bloomberg: Pro-gun towns must lack roads
- LeBron James returning to Cleveland Cavaliers
- PRUDEN: 'Dirty Harry' Reids increasing eccentricity
- Hamas orders civilians to die in Israeli airstrikes
- BRUCE: The feds plot to steal your paycheck
- Bush fixed bowling lanes that Obama wants to renovate
- White House urges GOP to act 'urgently' on $3.7 billion request for illegal immigrants
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq
World Cup's sexiest WAGs